1. Home
  2. EKSO vs ALUR Comparison

EKSO vs ALUR Comparison

Compare EKSO & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$7.27

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.58

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EKSO
ALUR
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
18.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EKSO
ALUR
Price
$7.27
$1.58
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$9.50
$9.25
AVG Volume (30 Days)
5.9M
87.0K
Earning Date
03-02-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,749,000.00
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$54.65
$15.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.73
$1.02
52 Week High
$12.70
$16.81

Technical Indicators

Market Signals
Indicator
EKSO
ALUR
Relative Strength Index (RSI) 48.80 48.00
Support Level $7.70 $1.65
Resistance Level $9.11 $1.93
Average True Range (ATR) 1.09 0.17
MACD -0.17 0.01
Stochastic Oscillator 1.29 52.48

Price Performance

Historical Comparison
EKSO
ALUR

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: